Back to LGND Stock Lookup

Ligand Pharma (LGND) –

Sep 23, 2016 04:20 PM Form 4 LIGAND PHARMACEUTICALS For: Sep 22 Filed by: HIGGINS JOHN L
Sep 22, 2016 04:06 PM Form 8-K LIGAND PHARMACEUTICALS For: Sep 22
Sep 22, 2016 10:50 AM Form 8-K LIGAND PHARMACEUTICALS For: Sep 22
Sep 22, 2016 09:02 AM Ligand Pharma (LGND) Enters Licensing Agreements with Seelos Therapeutics for Four Programs
Sep 22, 2016 09:00 AM Ligand Licenses Four Programs to Seelos Therapeutics
Sep 16, 2016 09:28 AM Form CT ORDER LIGAND PHARMACEUTICALS
Sep 16, 2016 09:00 AM Ligand Enters OmniAb® License Agreement with TeneoBio, Inc.
Sep 13, 2016 12:29 PM Roth Capital Affirms Ligand Pharma (LGND) at 'Buy' Following Initiation of LGD-6972 Phase 2 in T2D
Sep 13, 2016 08:30 AM Ligand Initiates Phase 2 Trial with LGD-6972 in Type 2 Diabetes
Sep 9, 2016 04:06 PM Form 4/A LIGAND PHARMACEUTICALS For: Sep 01 Filed by: KOZARICH JOHN W
Sep 9, 2016 04:06 PM Form 4 LIGAND PHARMACEUTICALS For: Sep 07 Filed by: KOZARICH JOHN W
Sep 7, 2016 12:04 PM Streetinsider.com's Hot Lunchtime Reads 9/7: (AMD) (LGND) (EXPR) (GILD)
Sep 7, 2016 11:00 AM Roth Capital Bumps PT on Ligand Pharma (LGND) up to $151 Following Sparsentan Data; Affirms at 'Buy'
Sep 7, 2016 10:14 AM Notable Analyst Rating Changes 9/7: (LGND) (GLPI) (DIN) Upgraded; (MNTA) (OLN) (TNXP) Downgraded
Sep 7, 2016 09:26 AM Ligand Pharma (LGND) Says Retrophin (RTRX) Presented Sparsentan Phase 2 Study Data
Sep 7, 2016 09:25 AM Ligand Partner Retrophin Announces Positive Top-Line Results from Phase 2 DUET Study of Sparsentan in Patients with Focal Segmental Glomerulosclerosis
Sep 7, 2016 07:40 AM Ligand Pharma (LGND) Gains After Retrophin (RTRX) Announces Positive Sparsentan Phase 2 Data
Sep 7, 2016 07:20 AM Deutsche Bank Upgrades Ligand Pharma (LGND) to Hold
Sep 7, 2016 06:53 AM Roth Capital Positive on Ligand Pharma (LGND) Ahead of Sept. Catalysts; Affirms at 'Buy'
Sep 6, 2016 06:07 PM Form 4 LIGAND PHARMACEUTICALS For: Sep 01 Filed by: KOZARICH JOHN W
Sep 2, 2016 09:00 AM Ligand to Participate in Two Upcoming Investor Conferences
Sep 1, 2016 06:00 AM Intec Pharma Reports First Half 2016 Financial Results
Aug 26, 2016 08:40 AM Ligand Pharma (LGND) Board Approves Ernst & Young as Independent Registered Accounting Firm
Aug 26, 2016 08:32 AM Form 8-K LIGAND PHARMACEUTICALS For: Aug 22
Aug 15, 2016 09:04 AM Ligand Pharma (LGND) Announces Publishing of Results from Phase 1 Trials with LGD-6972 in Type 2 Diabetes Mellitus
Aug 15, 2016 09:00 AM Results from Phase 1 Trials with Ligand’s LGD-6972 in Type 2 Diabetes Mellitus Published in Diabetes, Obesity and Metabolism
Aug 9, 2016 05:07 PM Form 4 LIGAND PHARMACEUTICALS For: Aug 05 Filed by: Berkman Charles S
Aug 9, 2016 04:59 PM Form 4 LIGAND PHARMACEUTICALS For: Aug 05 Filed by: FOEHR MATTHEW W
Aug 5, 2016 12:12 PM Streetinsider.com's Hot Lunchtime Reads 8/5: (MU) (MRK) (LGND) (FIVE)
Aug 5, 2016 11:27 AM Roth Capital Says to Buy Ligand Pharma (LGND) on Today's 'Bad' Downgrade
Aug 5, 2016 06:45 AM Deutsche Bank Downgrades Ligand Pharma (LGND) to Sell
Aug 4, 2016 04:24 PM Form 10-Q LIGAND PHARMACEUTICALS For: Jun 30
Aug 4, 2016 02:27 PM Roth Capital Bumps PT on Ligand Pharma (LGND) up to $149; Says Running on All Cylinders
Aug 4, 2016 09:07 AM Form 8-K LIGAND PHARMACEUTICALS For: Aug 04
Aug 4, 2016 08:56 AM Ligand Pharma (LGND) Tops Q2 EPS by 10c; Affirms FY16 Outlook
Aug 4, 2016 08:00 AM Ligand Reports Second Quarter 2016 Financial Results
Aug 3, 2016 02:51 PM Trading Radar for 8/4: Kellogg (K), MGM Resorts (MGM), Activision (ATVI), FireEye (FEYE), Weight Watchers (WTW) Report
Aug 2, 2016 07:47 PM Form 4 LIGAND PHARMACEUTICALS For: Aug 01 Filed by: KOZARICH JOHN W
Jul 29, 2016 04:32 PM Form S-8 LIGAND PHARMACEUTICALS
Jul 29, 2016 08:49 AM Form 8-K LIGAND PHARMACEUTICALS For: Jul 29
Jul 29, 2016 08:32 AM Ligand Pharma (LGND) Enters LTP Tech Licensing Agreement
Jul 29, 2016 08:30 AM Ligand Announces Multi-Program LTP Technology Licensing Agreement with Nucorion Pharmaceuticals
Jul 26, 2016 04:47 PM Form CT ORDER LIGAND PHARMACEUTICALS
Jul 19, 2016 04:46 PM Form CT ORDER LIGAND PHARMACEUTICALS
Jul 19, 2016 10:21 AM Roth Capital Affirms Ligand Pharma (LGND) Following Solid Q2 Revenue Results for Promacta (NVS)
Jul 14, 2016 09:00 AM Ligand to Report Second Quarter Results on August 4th
Jul 12, 2016 08:37 AM Roth Affirms Ligand Pharma (LGND) at 'Buy' Following Strong Severe PPD Data from SAGE Therapeutics (SAGE)
Jul 8, 2016 02:49 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: BlackRock Inc.
Jul 8, 2016 09:47 AM Roth Positive on Ligand Pharma (LGND) Amid Another Key OmniAb Collaboration (GILD)
Jul 8, 2016 09:02 AM Ligand Pharma (LGND) Enters OmniAb Licensing Agreement with Gilead (GILD)

Back to LGND Stock Lookup